What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA

Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.Read More

Tags

Share this post:

JOIN THE HYVE

Gain insights, receive dynamic opportunities directly to your inbox. Sign up now…